Latest Research in Cancer Immunotherapy and Biomarkers

Top Research Topics in Cancer Immunotherapy and Biomarkers

• Cancer Immunotherapy and Biomarkers — 11 papers
• Single-cell and spatial transcriptomics — 6 papers
• Epigenetics and DNA Methylation — 5 papers
• Cancer Cells and Metastasis — 5 papers
• Immunotherapy and Immune Responses — 3 papers
• NF-κB Signaling Pathways — 2 papers
• MicroRNA in disease regulation — 2 papers
• Cytokine Signaling Pathways and Interactions — 2 papers
• Phytochemicals and Medicinal Plants — 2 papers
• Sarcoma Diagnosis and Treatment — 2 papers

Highest-Cited Papers

1. A systemic neuroendocrine immune axis in breast cancer revealed by MMD regularized cross tissue latent alignment across four independent cohorts
2. Immunogenic cell death as a mechanism of synergy between sunitinib and 177Lu-DOTATATE peptide receptor radionuclide therapy in pancreatic neuroendocrine tumors
3. Siglec–15 promotes a feed-forward loop between TNBC cells and macrophages via the NF-κB/DcR3/CCL18/STAT3 axis
4. Construction of an m5Cscore based on m5C modification patterns to predict prognosis and personalized treatment outcomes in breast cancer
5. Fourth-generation chimeric antigen receptor T cells targeting mucin 1 for enhanced anti-tumor activity against breast cancer
6. Exploring spatial heterogeneity of PD-L1 and c-MET expression in oral squamous cell carcinoma
7. Granzyme B PET Imaging Reveals Lgmn + Macrophage‐Mediated Immune Evasion and Guides Immunotherapy in EGFR‐TKI‐Resistant NSCLC
8. PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma
9. Functions and mechanisms of ncRNAs in breast cancer immunotherapy and targeted therapy
10. Partial FAK suppression promotes tumor growth, an effect reversed by macrophage p110δ PI3K inactivation
11. Interleukin-1 receptor-associated kinase 1 controls chemoresistance and immuno-killing in non-small cell lung cancer
12. In vivo CRISPR screening links NFKB1 to endocrine resistance in ER+ breast cancer
13. Multi-omics analysis of cervical carcinogenesis reveals galectin-9 driven immune evasion as a candidate immunotherapeutic target
14. In Silico Modeling of a Mathematically Optimized Staggered Epigenetic Priming Regimen Range: Candidate 1 (WA / Quercetin / Silibinin Architecture)
15. Identification of functional genes and immune cell infiltration analysis in liposarcoma
16. In Silico Modeling of a Mathematically Optimized Staggered Epigenetic Priming Regimen Range: Candidate 1 (WA / Quercetin / Silibinin Architecture)
17. Anti‑cancer effects of the circadian clock modulating compound SR9009 in chordoma cell lines
18. A comparison of methods for analyzing DNA methylation from clinical archival macrodissected formalin-fixed paraffin-embedded tissue
19. Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: “Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia”
20. Exploratory integration of spatial transcriptomics and MRI phenotypes to characterize metastasis-associated microenvironmental features in ipsilateral breast tumor recurrence